Stable transplantation of human mitochondrial DNA by high-throughput, pressurized isolated mitochondrial delivery

Author:

Sercel Alexander J1ORCID,Patananan Alexander N2ORCID,Man Tianxing3,Wu Ting-Hsiang45,Yu Amy K1,Guyot Garret W2,Rabizadeh Shahrooz4567,Niazi Kayvan R4578,Chiou Pei-Yu378,Teitell Michael A12789ORCID

Affiliation:

1. Molecular Biology Interdepartmental Doctoral Program, University of California, Los Angeles, Los Angeles, United States

2. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States

3. Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, Los Angeles, United States

4. NanoCav, LLC, Culver City, United States

5. NantBio, Inc, and ImmunityBio, Inc, Culver City, United States

6. NantOmics, LLC, Culver City, United States

7. California NanoSystems Institute, University of California, Los Angeles, Los Angeles, United States

8. Department of Bioengineering, University of California, Los Angeles, Los Angeles, United States

9. Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research University of California, Los Angeles, Los Angeles, United States

Abstract

Generating mammalian cells with specific mitochondrial DNA (mtDNA)–nuclear DNA (nDNA) combinations is desirable but difficult to achieve and would be enabling for studies of mitochondrial-nuclear communication and coordination in controlling cell fates and functions. We developed ‘MitoPunch’, a pressure-driven mitochondrial transfer device, to deliver isolated mitochondria into numerous target mammalian cells simultaneously. MitoPunch and MitoCeption, a previously described force-based mitochondrial transfer approach, both yield stable isolated mitochondrial recipient (SIMR) cells that permanently retain exogenous mtDNA, whereas coincubation of mitochondria with cells does not yield SIMR cells. Although a typical MitoPunch or MitoCeption delivery results in dozens of immortalized SIMR clones with restored oxidative phosphorylation, only MitoPunch can produce replication-limited, non-immortal human SIMR clones. The MitoPunch device is versatile, inexpensive to assemble, and easy to use for engineering mtDNA–nDNA combinations to enable fundamental studies and potential translational applications.

Funder

National Institutes of Health

American Heart Association

National Science Foundation

Air Force Office of Scientific Research

CIRM

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3